Jul 13, 2026 09:05AM

Jul 13, 2026 09:05AM

Feb 25, 2026 08:20AM

Feb 23, 2026 04:05PM

Oct 29, 2025 09:01AM

Oct 29, 2025 09:00AM

Oct 28, 2025 09:23AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered at Truist; 'Competitive Pressures Mounting'

Oct 28, 2025 08:43AM

Aug 26, 2025 06:35AM

Jul 15, 2025 06:15AM

Jun 25, 2025 10:03AM

Apr 10, 2025 05:32AM

Sep 21, 2023 10:00AM

Sep 15, 2023 09:29AM BioMarin Pharma (BMRN) Receives Positive CHMP Opinion in Europe to Expand Use of VOXZOGO to Treat Children Aged 4 Months and Older with Achondroplasia

Sep 15, 2023 09:29AM

Jun 22, 2023 08:00AM

Apr 26, 2023 04:03PM

Mar 14, 2023 08:00AM

Mar 7, 2023 04:08PM

Mar 7, 2023 04:05PM

Mar 7, 2023 07:07AM Stifel Defending BioMarin Pharmaceutical Inc. (BMRN)

Mar 6, 2023 07:28PM

Feb 27, 2023 04:03PM

Jan 9, 2023 05:05AM

Jan 8, 2023 11:00AM

Jan 4, 2023 08:39AM

Nov 7, 2022 04:31PM

Nov 7, 2022 04:30PM BioMarin Announces Incremental Progress on Biologics License Application (BLA) Review for Valoctocogene Roxaparvovec AAV Gene Therapy for Adults with Severe Hemophilia A Program

Oct 26, 2022 04:03PM

Oct 12, 2022 05:12PM

Oct 12, 2022 04:05PM

Oct 12, 2022 04:05PM

Feb 9, 2022 08:31AM

Feb 9, 2022 08:31AM

Oct 28, 2021 06:20AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $84 at Oppenheimer

Oct 27, 2021 04:05PM

Aug 27, 2021 09:51AM

Aug 27, 2021 09:02AM

Aug 27, 2021 09:01AM

Aug 24, 2021 07:20AM

Jul 28, 2021 04:03PM

Jun 25, 2021 07:30AM BioMarin Pharma (BMRN) Receives Positive CHMP Opinion in Europe for Vosoritide for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close

Jun 25, 2021 07:29AM

Jun 22, 2021 07:15AM

Apr 29, 2021 04:03PM

Apr 15, 2021 08:35AM

Apr 15, 2021 08:31AM

Mar 20, 2021 11:15AM

Mar 3, 2021 08:32AM BioMarin Pharma (BMRN) Reports Complete Full Enrollment in Phase 2 Study of Vosoritide

Mar 3, 2021 08:31AM

15,533 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All